Big 3 Generic Makers Log 7.2% Growth in 1st Half, Suffer Sluggish Japan Sales on Price Cuts, COVID-19: Jiho Tally

November 20, 2020
Japan’s top-three generic makers collectively recorded a sales rise of 7.2% in April-September, with most of its growth resulting from the acquisition of a Spanish generic maker by Towa Pharmaceutical earlier this year. In the home market, however, the three...read more